ImmunityBio
IBRX
IBRX
85 hedge funds and large institutions have $129M invested in ImmunityBio in 2020 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
3.71% more ownership
Funds ownership: 6.19% → 9.9% (+3.7%)
20% less call options, than puts
Call options by funds: $5.27M | Put options by funds: $6.59M
Holders
85
Holding in Top 10
1
Calls
$5.27M
Puts
$6.59M
Top Buyers
| 1 | +$16.9M | |
| 2 | +$9.68M | |
| 3 | +$6.27M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$6.13M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$5.24M |
Top Sellers
| 1 | -$20.3M | |
| 2 | -$1.9M | |
| 3 | -$369K | |
| 4 |
Goldman Sachs
New York
|
-$232K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$230K |